Article
A two-drug combination for metastatic melanoma reduced the odds of progression by 60 percent, demonstrating more effectiveness than monotherapy, according to researchers.
Daily Derm Times: February 12, 2025
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Should “Advanced Practice Provider” Represent Both PAs and NPs?
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Trauma-Induced Melanocyte Implantation Leading to Subcutaneous Melanoma
Reviewing Complex Cases: Special Issues in AD Comorbidities